-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QOwf7NVodwL36UoKdYwtXnGut8xxq/AmMJeoHsQ3b5yz03/jEitGH8l8z9odzZmH
 rVi3LV1ZlgDhqqn3XZkAvw==

<SEC-DOCUMENT>0001203311-03-000046.txt : 20031126
<SEC-HEADER>0001203311-03-000046.hdr.sgml : 20031126
<ACCEPTANCE-DATETIME>20031126191658
ACCESSION NUMBER:		0001203311-03-000046
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20031125
FILED AS OF DATE:		20031126

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LIPPMAN MARC E
		CENTRAL INDEX KEY:			0001202794

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-50266
		FILM NUMBER:		031027742

	MAIL ADDRESS:	
		STREET 1:		DEPT INTERNAL MED MICIGAN U HEALTH SYS
		STREET 2:		3110 TAUBMAN CENTER RESEACH BLDG E501
		CITY:			ANN ARBORAN FRANCISCO
		STATE:			MI
		ZIP:			48109

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SEATTLE GENETICS INC /WA
		CENTRAL INDEX KEY:			0001060736
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				911874389
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		21823 30TH DRIVE SE
		STREET 2:		SUITE
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4255274000

	MAIL ADDRESS:	
		STREET 1:		21823 30TH DRIVE SE
		STREET 2:		SUITE
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgardoc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2003-11-25</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001060736</issuerCik>
        <issuerName>SEATTLE GENETICS INC /WA</issuerName>
        <issuerTradingSymbol>SGEN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001202794</rptOwnerCik>
            <rptOwnerName>LIPPMAN MARC E</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>UNIVERSITY OF MICHIGAN HEALTH SYSTEM</rptOwnerStreet1>
            <rptOwnerStreet2>3110 TAUBMAN CENTER, RESEARCH BLDG E501</rptOwnerStreet2>
            <rptOwnerCity>ANN ARBOR</rptOwnerCity>
            <rptOwnerState>MI</rptOwnerState>
            <rptOwnerZipCode>48109</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>

        <derivativeTransaction>
            <securityTitle>
                <value>Non-Qualified Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.34</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2003-11-25</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>20000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2004-11-25</value>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2013-11-25</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>20000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>20000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>

    </derivativeTable>

    <footnotes>
        <footnote id="F1">Shares shall vest at a rate of 25% on 11/25/04 and monthly thereafter until all shares are vested 11/25/07.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>By: Clay B. Siegall  For: Marc E. Lippman</signatureName>
        <signatureDate>2003-11-26</signatureDate>
    </ownerSignature>

</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----